First And Only Flt3 Inhibitor Approved Across Three Phases Of Aml Treatment Based On Quantum-First Results Demonstrating Vanflyta Added To Chemotherapy Improved Overall SurvivalThird Innovative Medicine From The Oncology Pipeline Of Daiichi Sankyo Approved In The U.S.Daiichi Sankyo Announced That Vanflyta
